Avid Bioservices Inc (CDMO)

[2ndstr2thert]

ON THE SHELF 3

TECHNICLONE ISSUED PATENT ON VASOPERMEATION ENHANCEMENT.
Feb, 2000
Biotech Business
Techniclone Corporation (NASDAQ:TCLN), Tustin, Calif., has announced that the U.S. Patent Office has granted a US Patent No. 6007817 for Techniclone's Vasopermeation Enhancement Agent ("VEA") technology. The VEA technology is one of Techniclone's platform technologies, which will be used to enhance drug uptake in solid tumors. This broad patent covers the use of the VEA agents for the treatment of all solid tumors in conjunction with chemotherapeutic agents, monoclonal antibodies, cytokines and other therapeutic agents.

The technology was developed to be administered prior to the administration of most existing cancer therapies. Preclinical studies in animal models have shown that drug uptake can be increased up to 400% in specific instances by using the VEA technology as a pretreatment.
http://www.entrepreneur.com/tradejournals/article/58674378.html






iHub NewsWire

--------------------------------------------------------------------------------
DBMM Looks to Acquisition to Grow Digital Clarity Brand(DBMMD) Jul 20, 2015 12:40 PM North American Cannabis Holdings Announces NaturesComfortMeds JV In Conjunction With Aug 3rd Spin-off And Shareholder Dividend(USMJ) Jul 20, 2015 9:33 AM SourcingLink.net; Eldor Property Phase 1 Exploration Announcement(SNET) Jul 20, 2015 8:30 AM Fresh Healthy Vending and American Diabetes Association Partner to Promote Corporate Initiative "Wellness Lives Here"(VEND) Jul 20, 2015 8:12 AM QUASAR ANNOUNCES MANAGEMENT CHANGE(QASP) Jul 17, 2015 1:00 PM

Around the Web

--------------------------------------------------------------------------------







Public Reply | Private Reply | Keep | Last Read

Post New Msg

Replies (1) | Next 10 | Previous | Next






Follow Board

Follow User

Ignore User

Keyboard Shortcuts

Report TOS Violation

















































© 2015 InvestorsHub.Com, Inc.



About
Investor Relations (OTC:IHUBY)
About Us
Terms of Service
Privacy Policy
Advertise With Us
Investor Relations
Data Accreditations
Disclaimer


Help
FAQ
Site Map
Handbook
Q&A Forum
Contact Us
Tutorials


Educational
Educational Channel
Stock Market 101
Educational Videos
Investor Help Forum


More
iHub on Facebook
iHub on Twitter
iHub iPhone/iPad App
iHub Android App
iHub BlackBerry App
StockWiki
Auditorium
iHub NewsWire


You are 2ndstr2thert on WEB3